Preclinical and clinical development advice of pharmaceutical products and medical devices
Clinical Plan development tailored for our costumers’ needs
Regulatory requirements forecast to improve our customers’ product development strategy
Strategy and Scope definition of pharmacology studies for our clients’ biologic and medical device assets
Biostrike is a consultancy firm specialized in preclinical, clinical development of pharmaceutical products and medical devices
Clinical expertise to help our clients have a strong and fully compliant development package
Straightforward execution of your plans. Biostrike provides straight-to-the point strategies for the execution of client’s projects
Defining the strategy and scope of pharmacology studies for our clients’ biologic assets
Project NEUROSENSE (NEUROendocrine SENSor for Sudden Unexpected Death in Epilepsy prediction and prevention) has been approved in the highly-competitive context of EU Horizon EUROPE Pathfinder Open call, with 4M€ funding. The project will be developed under the leadership of...
The COVID-19 pandemic is disrupting clinical research worldwide as enrolment in active clinical trials has been severely affected. Since early March several clinical trials have been halted or delayed accordingly with clinicaltrials.gov due to COVID-19 spread. In order to...
